Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
ICD-10 F13.14 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder.
F13.14 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to a mood disorder induced by these substances. Patients may misuse medications such as benzodiazepines or barbiturates, resulting in significant psychological and physical dependence. The mood disorder can manifest as depression, anxiety, or other mood disturbances, complicating the clinical picture. This code is essential for capturing the dual diagnosis of substance abuse and mood disorder, which requires a comprehensive treatment approach. Treatment may involve detoxification, psychotherapy, and medication management to address both the substance use disorder and the mood disorder. Accurate coding is crucial for appropriate reimbursement and treatment planning.
Detailed psychiatric evaluation, including substance use history and mood assessment.
Patients presenting with anxiety or depression who have a history of sedative use.
Ensure clear differentiation between primary mood disorders and those induced by substance use.
Comprehensive substance use assessment and treatment plan.
Patients undergoing detoxification from sedatives with concurrent mood disturbances.
Focus on the integration of mental health and addiction treatment strategies.
Used for follow-up visits for patients with dual diagnoses.
Document the patient's history, examination findings, and treatment plan.
Psychiatry may require additional mental status examination details.
Coding F13.14 is crucial for accurately reflecting the patient's condition, ensuring appropriate treatment planning, and facilitating reimbursement for services addressing both substance use and mood disorders.